Biolase (BIOL) Tops Q4 EPS by 7c

Biolase (NASDAQ: BIOL) reported Q4 EPS of ($0.02), $0.07 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $13.9 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BMO starts chip stocks coverage: Here are its preferred picks
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04